Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Hematology diagnostics industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Product trends
2.5 Test Type trends
2.6 End-use trends
Chapter 3 Hematology Diagnostics Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of blood & related disorders
3.2.1.2 Rising awarness regarding diagnosis of targeted diseases
3.2.1.3 Technological advancements in heamtology diagnostics
3.2.1.4 Increasing adoption of point-of-care testing in developing countries
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of hematology diagnostics
3.2.2.2 Lack of reimbursement and inadequate insurance coverage
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By test type
3.3.3 By end use
3.4 COVID- 19 impact analysis
3.5 Pricing analysis, 2022, by region
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Pricing analysis, 2022
3.8 Reimbursement scenario
3.9 Key market trends
3.10 Technology landscape
3.11 Value chain analysis
3.12 Initiative landscape
3.13 Gap Analysis
3.14 Porter's analysis
3.15 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Vendor matrix analysis
4.5 Competitive positioning matrix
4.6 Strategy dashboard, 2022
Chapter 5 Hematology Diagnostics Market Size and Forecast, By Product (USD Million & Units)
5.1 Key trends, by product
5.2 Instruments
5.3 Consumables
Chapter 6 Hematology Diagnostics Market Size and Forecast, By Test Type (USD Million)
6.1 Key trends, by test type
6.2 Blood count
6.3 Platelet function
6.4 Hemoglobin
6.5 Hematocrit
6.6 Others
Chapter 7 Hematology Diagnostics Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Others
Chapter 8 Hematology Diagnostics Market Size and Forecast, By Region (USD Million & Units)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Switzerland
8.3.8 The Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Vietnam
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Colombia
8.5.5 Chile
8.5.6 Peru
8.6 MEA
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Egypt
8.6.6 Turkey
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 BAG Healthcare Ltd.
9.3 Beckman Coulter, Inc.
9.4 Bio-Rad Laboratories
9.5 BioSystems
9.6 Boule Diagnostics
9.7 Danaher
9.8 Diatron
9.9 F. Hoffmann-La Roche Ltd.
9.10 HemoCue AB
9.11 HORIBA
9.12 Mindray Medical International Limited
9.13 Nihon Kohden
9.14 Ortho Clinical Diagnostics
9.15 Siemens Healthcare
9.16 Sysmex Corporation
